Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice

European Journal of Pharmacology

Volumn 744, Issue , 2015, Pages 124-131

  Sulakhiya, Kunjbihari ^a   Kumar, Parveen ^b   Jangra, Ashok ^a   Dwivedi, Shubham ^a   Hazarika, Naba K ^c   Baruah, Chandana C ^d   Lahkar, Mangala ^c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^c Guwahati Medical College   (India)

^d ASSAM AGRICULTURAL UNIVERSITY   (India)

Author keywords

Depression; Honokiol; Lipopolysaccharide; Neuroinflammation; Oxido nitrosativestress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; GLUTATHIONE; HONOKIOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; BIPHENYL DERIVATIVE; LIGNAN; LIPOPOLYSACCHARIDE; NITRITE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; FORCED SWIM TEST; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NITROSATIVE STRESS; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PREFRONTAL CORTEX; SUCROSE PREFERENCE TEST; TAIL SUSPENSION TEST; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIPHENYL COMPOUNDS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; GLUTATHIONE; HIPPOCAMPUS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIGNANS; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MICE; NITRITES; OXIDATIVE STRESS; PREFRONTAL CORTEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84918807004     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.09.049     Document Type: Article

References (71)

1. S. Ali, M.A. Stone, J.L. Peters, M.J. Davies, and K. Khunti The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis Diabet. Med. 23 2006 1165 1173
2. S. Arora, A. Bhardwaj, S.K. Srivastava, S. Singh, S. McClellan, B. Wang, and A.P. Singh Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells PLoS One 6 2011 e21573
3. H.O. Besedovsky, and A. del Rey The cytokine-HPA axis feed-back circuit Z. Rheumatol. 59 2000 II26 II30
4. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J. Lab. Clin. Med. 61 1963 882 888
5. E. Bromet, L.H. Andrade, I. Hwang, N.A. Sampson, J. Alonso, G. de Girolamo, R. de Graaf, K. Demyttenaere, C. Hu, N. Iwata, A.N. Karam, J. Kaur, S. Kostyuchenko, J.P. Lepine, D. Levinson, H. Matschinger, M.E. Mora, M.O. Browne, J. Posada-Villa, M.C. Viana, D.R. Williams, and R.C. Kessler Cross-national epidemiology of DSM-IV major depressive episode BMC Med. 9 2011 90
6. L.K. Chao, P.C. Liao, C.L. Ho, E.I. Wang, C.C. Chuang, H.W. Chiu, L.B. Hung, and K.F. Hua Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression J. Agric. Food Chem. 58 2010 3472 3478
7. C.M. Chen, S.H. Liu, and S.Y. Lin-Shiau Honokiol, a neuroprotectant against mouse cerebral ischaemia, mediated by preserving Na+, K+-ATPase activity and mitochondrial functions Basic Clin. Pharmacol. Toxicol. 101 2007 108 116
8. C.K. Chiang, M.L. Sheu, Y.W. Lin, C.T. Wu, C.C. Yang, M.W. Chen, K.Y. Hung, K.D. Wu, and S.H. Liu Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro Br. J. Pharmacol. 163 2011 586 597
9. A.M. Codori, P.R. Slavney, A. Rosenblatt, and J. Brandt Prevalence of major depression one year after predictive testing for Huntingtons disease Genet. Test. 8 2004 114 119
10. P.J. Cowen Cortisol, serotonin and depression: all stressed out? Br. J. Psychiatry 180 2002 99 100
11. A. Dhir, and S.K. Kulkarni Nitric oxide and major depression Nitric Oxide 24 2011 125 131
12. S. Dikalov, T. Losik, and J.L. Arbiser Honokiol is a potent scavenger of superoxide and peroxyl radicals Biochem. Pharmacol. 76 2008 589 596
13. L.E. Fried, and J.L. Arbiser Honokiol, a multifunctional antiangiogenic and antitumor agent Antioxid. Redox Signal. 11 2009 1139 1148
14. P. Galecki, E. Galecka, M. Maes, M. Chamielec, A. Orzechowska, K. Bobinska, A. Lewinski, and J. Szemraj The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder J. Affect. Disord. 138 2012 360 366
15. J.P. Godbout, J. Chen, J. Abraham, A.F. Richwine, B.M. Berg, K.W. Kelley, and R.W. Johnson Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system FASEB J. 19 2005 1329 1331
16. 15N] nitrate in biological fluids Anal. Biochem. 126 1982 131 138
17. Y. Gustafson, I. Nilsson, M. Mattsson, M. Astrom, and G. Bucht Epidemiology and treatment of post-stroke depression Drugs Aging 7 1995 298 309
18. J. Hannestad, N. DellaGioia, and M. Bloch The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis Neuropsychopharmacology 36 2011 2452 2459
19. C.J. Henry, Y. Huang, A. Wynne, M. Hanke, J. Himler, M.T. Bailey, J.F. Sheridan, and J.P. Godbout Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia J. Neuroinflamm. 5 2008 2094 2095
20. H. Hu, X.X. Zhang, Y.Y. Wang, and S.Z. Chen Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin Acta Pharmacol. Sin. 26 2005 1063 1068
21. Y. Huang, C.J. Henry, R. Dantzer, R.W. Johnson, and J.P. Godbout Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide Neurobiol. Aging 29 2008 1744 1753
22. A. Jangra, A.K. Datusalia, S. Khandwe, and S.S. Sharma Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: Implication of oxidative stress-PARP pathway Pharmacol. Biochem. Behav. 114 2013 43 51
23. S.R. Joca, and F.S. Guimaraes Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects Psychopharmacology (Berl.) 185 2006 298 305
24. E.R. Kasala, L.N. Bodduluru, Y. Maneti, and R. Thipparaboina Effect of meditation on neurophysiological changes in stress mediated depression Complement. Ther. Clin. Pract. 20 2014 74 80
25. M.P. Kaster, P.K. Ferreira, A.R. Santos, and A.L. Rodrigues Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway Behav. Brain Res. 165 2005 204 209
26. M.P. Kaster, V.M. Gadotti, J.B. Calixto, A.R. Santos, and A.L. Rodrigues Depressive-like behavior induced by tumor necrosis factor-alpha in mice Neuropharmacology 62 2012 419 426
27. D.K. Kaushik, R. Mukhopadhyay, K.L. Kumawat, M. Gupta, and A. Basu Therapeutic targeting of Kruppel-like factor 4 abrogates microglial activation J. Neuroinflamm. 9 2012 57
28. B.H. Kim, and J.Y. Cho Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression1 Acta Pharmacol. Sin. 29 2008 113 122
29. H. Kuribara, W.B. Stavinoha, and Y. Maruyama Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice J. Pharm. Pharmacol. 51 1999 97 103
30. B.H. Lee, S.W. Lee, D. Yoon, H.J. Lee, J.C. Yang, S.H. Shim, D.H. Kim, S.H. Ryu, C. Han, and Y.K. Kim Increased plasma nitric oxide metabolites in suicide attempters Neuropsychobiology 53 2006 127 132
31. B. Leonard, and M. Maes Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neurosci. Biobehav. Rev. 36 2012 764 785
32. C.Y. Li, L.K. Chao, S.C. Wang, H.Z. Chang, M.L. Tsai, S.H. Fang, P.C. Liao, C.L. Ho, S.T. Chen, W.C. Cheng, C.S. Chiang, Y.H. Kuo, K.F. Hua, and I.C. Hsu Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells J. Cell. Physiol. 226 2011 2338 2349
33. J. Li, X. Shao, L. Wu, T. Feng, C. Jin, M. Fang, N. Wu, and H. Yao Honokiol: an effective inhibitor of tumor necrosis factor-alpha-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts Acta Biochim. Biophys. Sin. (Shanghai) 43 2011 380 386
34. Y.R. Lin, H.H. Chen, C.H. Ko, and M.H. Chan Effects of honokiol and magnolol on acute and inflammatory pain models in mice Life Sci. 81 2007 1071 1078
35. Y. Liu, and Y. Peng 2. TNF-alpha mediates depressive-like behavior induced by chronic mild stress through upregulation of indoleamine 2, 3-dioxygenase in mice Brain Behav. Immun. 32 2013 e1
36. N.L. Lopez-Duran, M. Kovacs, and C.J. George Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis Psychoneuroendocrinology 34 2009 1272 1283
37. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
38. J.L. Madrigal, O. Hurtado, M.A. Moro, I. Lizasoain, P. Lorenzo, A. Castrillo, L. Bosca, and J.C. Leza The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress Neuropsychopharmacology 26 2002 155 163
39. M. Maes Evidence for an immune response in major depression: a review and hypothesis Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1995 11 38
40. M. Maes The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression NeuroEndocrinol. Lett. 29 2008 287 291
41. M. Maes, Z. Fisar, M. Medina, G. Scapagnini, G. Nowak, and M. Berk New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors Inflammopharmacology 20 2011 127 150
42. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 676 692
43. M. Maes, M. Kubera, E. Obuchowiczwa, L. Goehler, and J. Brzeszcz Depressions multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways NeuroEndocrinol. Lett. 32 2011 7 24
44. M. Maes, B.E. Leonard, A.M. Myint, M. Kubera, and R. Verkerk The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 702 721
45. M. Maes, I. Mihaylova, M. Kubera, J.C. Leunis, and M. Geffard IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology J. Affect. Disord. 135 2011 414 418
46. M.J. Massie Prevalence of depression in patients with cancer JNCI Monogr. 2004 2004 57 71
47. W.M. McDonald, I.H. Richard, and M.R. DeLong Prevalence, etiology, and treatment of depression in Parkinsons disease Biol. Psychiatry 54 2003 363 375
48. B.S. Mello, A.S. Monte, R.S. McIntyre, J.K. Soczynska, C.S. Custodio, R.C. Cordeiro, J.H. Chaves, S.M. Vasconcelos, H.V. Nobre Jr., F.C. Florenco de Sousa, T.N. Hyphantis, A.F. Carvalho, and D.S. Macedo Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration J. Psychiatr. Res. 47 2013 1521 1529
49. M.E. Munroe, J.L. Arbiser, and G.A. Bishop Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis J. Immunol. 179 2007 753 763
50. D.L. Musselman, D.L. Evans, and C.B. Nemeroff The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment Arch. Gen. Psychiatry 55 1998 580 592
51. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
52. J.C. O'Connor, M.A. Lawson, C. Andre, M. Moreau, J. Lestage, N. Castanon, K.W. Kelley, and R. Dantzer Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice Mol. Psychiatry 14 2009 511 522
53. J. Park, J. Lee, E. Jung, Y. Park, K. Kim, B. Park, K. Jung, E. Park, J. Kim, and D. Park In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp Eur. J. Pharmacol. 496 2004 189 195
54. S.B. Patten, C.A. Beck, J.V. Williams, C. Barbui, and L.M. Metz Major depression in multiple sclerosis: a population-based perspective Neurology 61 2003 1524 1527
55. S. Pitta, B.B. Augustine, E.R. Kasala, K. Sulakhiya, V. Ravindranath, and M. Lahkar Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice Pharmacogn. J. 5 2013 211 215
56. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. Ther. 229 1977 327 336
57. L.Q. Qiang, C.P. Wang, F.M. Wang, Y. Pan, L.T. Yi, X. Zhang, and L.D. Kong Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats Arch. Pharm. Res. 32 2009 1281 1292
58. L. Qin, X. Wu, M.L. Block, Y. Liu, G.R. Breese, J.S. Hong, D.J. Knapp, and F.T. Crews Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration Glia 55 2007 453 462
59. P. Santosh, R. Venugopl, A.S. Nilakash, S. Kunjbihari, and L. Mangala Antidepressant activity of methanolic extract of Passiflora foetida leaves in mice Int. J. Pharm. Pharm. Sci. 3 2011 112 115
60. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl.) 85 1985 367 370
61. K. Sugino, K. Dohi, K. Yamada, and T. Kawasaki The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants Surgery 101 1987 746 752
62. E. Suzuki, G. Yagi, T. Nakaki, S. Kanba, and M. Asai Elevated plasma nitrate levels in depressive states J. Affect. Disord. 63 2001 221 224
63. S.K. Tsai, C.H. Huang, S.S. Huang, L.M. Hung, and C.Y. Hong Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin Pharmacology 59 1999 227 233
64. R. Uher, O. Mors, M. Rietschel, A. Rajewska-Rager, A. Petrovic, A. Zobel, N. Henigsberg, J. Mendlewicz, K.J. Aitchison, A. Farmer, and P. McGuffin Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study J. Clin. Psychiatry 72 2011 1478 1484
65. F. van Heesch, J. Prins, J.P. Konsman, K.G. Westphal, B. Olivier, A.D. Kraneveld, and S.M. Korte Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study Brain Behav. Immun. 29 2013 453 462
66. X. Wang, X. Duan, G. Yang, X. Zhang, L. Deng, H. Zheng, C. Deng, J. Wen, N. Wang, C. Peng, X. Zhao, Y. Wei, and L. Chen Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model PLoS One 6 2011 e18490
67. Y. Wang, Z.Z. Zhang, Y. Wu, J. Zhan, X.H. He, and Y.L. Wang Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation Exp. Ther. Med. 5 2013 315 319
68. WHO, 2008. Global burden of disease: 2004 update. World Health Organization, Geneva. "http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full.pdf" (accessed 11.03.14.).
69. T.H. Wu, and C.H. Lin IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions Behav. Brain Res. 193 2008 183 191
70. Q. Xu, L.T. Yi, Y. Pan, X. Wang, Y.C. Li, J.M. Li, C.P. Wang, and L.D. Kong Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 715 725
71. C. Zhao, and Z.Q. Liu Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA Biochimie 93 2011 1755 1760